Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026

AI Briefing

• – Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
• – Late-stage clinical biopharmaceutical company developing therapeutics for psychiatric and neurological disorders
• – Presentations and live Q&A sessions with executive leadership and external key opinion leaders